Terms ending in 2034
Every in-force patent on MiMedx Group, Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,655,948 | Non-Surgical, Localized Delivery of Compositions for Placental Growth Factors In force · High confidence | MiMedx Group, Inc. | In force | High confidence | |
| US 9,827,293 | Non-Surgical, Localized Delivery of Compositions for Placental Growth Factors In force · High confidence | MiMedx Group, Inc. | In force | High confidence | |
| US 10,517,931 | Non-Surgical, Localized Delivery of Compositions for Placental Growth Factors In force · High confidence | MiMedx Group, Inc. | In force | High confidence | |
| US 11,690,896 | Non-Surgical, Localized Delivery of Compositions for Placental Growth Factors In force · High confidence | MiMedx Group, Inc. | In force | High confidence | |
| US 9,446,142 | Polymer Chelator Conjugates In force · High confidence | MiMedx Group, Inc. | In force | High confidence | |
| US 11,000,553 | Placental Tissue Composition for for Treating Cardiac Tissue Damage In force · High confidence | MiMedx Group, Inc. | In force | High confidence | |
| US 10,857,266 | Reinforced Placental Tissue Grafts and Methods of Making and Using the Same In force · High confidence | MiMedx Group, Inc. | In force | High confidence |
7 of 7 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.